Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 06:11 am Purchase | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Blackstone Holdings I/II GP L.L.C. | 1,706,408 6.400% | 19,184 (+1.14%) | Filing History |
| 2022-02-10 08:48 am Sale | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -1,509,500 (Position Closed) | Filing History |
| 2022-02-02 4:55 pm Sale | 2021-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 2,459,021 9.300% | -500,000 (-16.90%) | Filing History |
| 2021-12-27 4:12 pm Purchase | 2021-12-14 | 13G | Galera Therapeutics, Inc. GRTX | Citadel Advisors LLC | 171,733 0.600% | 171,733 (New Position) | Filing History |
| 2021-10-20 3:42 pm Sale | 2021-10-19 | 13G | Galera Therapeutics, Inc. GRTX | HIRSCHMAN ORIN | 0 0.000% | -2,095,291 (Position Closed) | Filing History |
| 2021-06-07 06:18 am Purchase | 2021-05-24 | 13G | Galera Therapeutics, Inc. GRTX | HIRSCHMAN ORIN | 2,095,291 11.000% | 358,969 (+20.67%) | Filing History |
| 2021-04-29 6:19 pm Purchase | 2021-04-29 | 13G | Galera Therapeutics, Inc. GRTX | HIRSCHMAN ORIN | 1,736,322 11.000% | 1,736,322 (New Position) | Filing History |
| 2021-02-16 5:01 pm Purchase | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Blackstone Holdings I/II GP L.L.C. | 1,687,224 6.800% | 1,687,224 (New Position) | Filing History |
| 2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Venrock Healthcare Capital Partners III, L.P. | 917,860 3.700% | -825,528 (-47.35%) | Filing History |
| 2021-02-11 07:45 am Purchase | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,509,500 6.050% | 209,500 (+16.12%) | Filing History |
| 2021-02-08 4:58 pm Sale | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novo Holdings A/S | 2,959,021 11.900% | -450,000 (-13.20%) | Filing History |
| 2021-02-01 3:50 pm Sale | 2020-12-31 | 13G | Galera Therapeutics, Inc. GRTX | Novartis Bioventures Ltd | 2,467,960 9.890% | -1,075,107 (-30.34%) | Filing History |
| 2020-11-04 4:52 pm Purchase | 2020-10-16 | 13G | Galera Therapeutics, Inc. GRTX | Venrock Healthcare Capital Partners III, L.P. | 1,743,388 7.000% | 1,743,388 (New Position) | Filing History |